1 day ago · NEW YORK/FRANKFURT, Feb 10 (Reuters) - Merck KGaA (MRCG.DE), opens new tab, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and rare ...

Feb 4, 2025 · The latest international Merck & Co Inc news and views from Reuters - one of the world's largest news agencies

2 days ago · Merck, in a statement, said its negotiations to buy SpringWorks are ongoing, confirming an earlier report from Reuters. The Darmstadt, Germany-based company said that no legally binding agreement ...

1 day ago · -- Germany's Merck KGaA is in advanced talks to buy U.S. cancer and rare diseases biotech company Springworks Therapeutics, Reuters says, citing unnamed sources. -- The deal could be finalized in ...

5 days ago · Get Merck & Co Inc (MRK.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

By Sabrina Valle and Patricia Weiss. NEW YORK/FRANKFURT (Reuters) -Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and rare ...

By Sabrina Valle and Patricia Weiss NEW YORK/FRANKFURT (Reuters) -Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker ...

14 hours ago · German pharma Merck KGaA is currently in “ advanced discussions ” with SpringWorks Therapeutics regarding a potential acquisition. The news, first reported by Reuters Monday and confirmed by Merck KGaA a few hours later, sent the cancer biotech’s stocks soaring 34% and brought its value to approximately $4 billion at market close.. Merck KGaA insisted in its news release that “no ...

1 day ago · In 2015, Merck agreed to buy U.S. lab equipment supplier Sigma-Aldrich for $17 billion. Merck, which has a market value of 61.25 billion euros ($63.13 billion) has suffered high-profile setbacks recently in late-stage drug trials, prompting it to halt development of head and neck cancer drug xevinapant.

10 hours ago · Reuters was the first to report the potent. On Monday, Germany-based Merck KGaA (OTC:MKGAF) (OTC:MKKGY) reacted to press reports and confirmed advanced discussions with SpringWorks Therapeutics ...